Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 756520-70-4 | MDL No. : | MFCD09746214 |
Formula : | C18H28BNO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UCVPIGRFCZZOSL-UHFFFAOYSA-N |
M.W : | 333.23 | Pubchem ID : | 46739085 |
Synonyms : |
|
Num. heavy atoms : | 24 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.67 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 99.23 |
TPSA : | 40.16 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.53 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.54 |
Log Po/w (WLOGP) : | 1.32 |
Log Po/w (MLOGP) : | 0.97 |
Log Po/w (SILICOS-IT) : | 2.1 |
Consensus Log Po/w : | 1.39 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.36 |
Solubility : | 0.145 mg/ml ; 0.000435 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.03 |
Solubility : | 0.311 mg/ml ; 0.000933 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.7 |
Solubility : | 0.00659 mg/ml ; 0.0000198 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.46 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501 | UN#: | |
Hazard Statements: | H302-H312-H332 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With caesium carbonate; potassium iodide; In DMF (N,N-dimethyl-formamide); at 65℃; for 12h; | To a stirred solution of 3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboralan-2-yl)-phenol (1 g, 4.5 mmol from Aldrich) in DMF (100 mL) was added 4-(2-chloroethyl)-morpholine.HCl (930 mg, 5 mmol), Cs2CO3, and KI (40 mg, 0.24 mmol). The suspension was heated to 65 C. for 12 hours, at which time all starting material was consumed. The reaction was cooled, ethyl acetate was added (150 mL) and the organics were extracted with saturated sodium bicarbonate solution. The organics were separated, dried over MgSO4, and dried in vacuo yielding 4-{2-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboralan-2-yl)-phenoxy]-ethyl}-morpholine as a white crystalline solid in 78% yield. [0802] 1H NMR (CDCl3, 300 MHz) delta 1.34 (s, 12H), 2.56-2.59 (t, J=4.6, 4H), 2.8-2.88 (m, 2H), 3.71-3.74 (t, J=4.6, 2H), 4.14-4.18 (m, 2H), 7.2-7.4 (m, 4H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
69% | 60 Synthesis of 4-{2-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboralan-2-yl)-phenoxy]-ethyl}-morpholine: Synthesis of 4-{2-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboralan-2-yl)-phenoxy]-ethyl}-morpholine: To a stirred solution of 3-(4,4,5,5-tetramethyl-[1,3,2] dioxaboralan-2-yl)-phenol (1 g, 4.5 mmol from Aldrich) in DMF (100 mL) was added 4-(2-chloro-ethyl)-morpholine.HCl (930 mg, 5 mmol), Cs2CO3, and KI (40 mg, 0.24 mmol). The suspension was heated to 65° C. for 12 hours, at which time all starting material was consumed. The reaction was cooled, ethyl acetate was added (150 mL) and the organics were extracted with saturated sodium bicarbonate solution. The organics were separated, dried over MgSO4, and dried in vacuo yielding 4-{2-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboralan-2-yl)-phenoxy]-ethyl}-morpholine as a white crystalline solid in 78% yield. 1H NMR (CDCl3, 300 MHz) δ 1.34 (s, 12H), 2.56-2.59 (t, J=4.6, 4H), 2.8-2.88 (m, 2H), 3.71-3.74 (t, J=4.6, 2H), 4.14-4.18 (m, 2H), 7.2-7.4 (m, 4H). Using Method 2, the Example 60 was obtained in 69% yield from Example 6 and 4-{2-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaboralan-2-yl)-phenoxy]-ethyl}-morpholine. 1H-NMR (400 MHz, DMSO-d6) δ 7.63 (d, 1H), 7.52 (s, 1H), 7.47 (d, 1H), 7.38 (d, 1H), 7.13 (d, 1H), 7.04 (s, 1H), 6.95 (m, 1H), 6.26 (br s, 1H), 4.14 (m, 2H), 3.73 (m, 4H), 2.97 (m, 1H), 2.82 (m, 2H), 2.60 (m, 4H), 2.90 (m, 2H), 0.67 (m, 2H). MS m/z 380 [M++1]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With caesium carbonate In 1,4-dioxane; water at 120℃; for 0.333333h; Inert atmosphere; microwave irradiation; | 63 Example 63 Synthesis of 5-chloro-3-((5-(3-(2-morpholinoethoxy)phenyl)furan-2-yl)methylene)indolin-2-one To 3-((5-bromofuran-2-yl)methylene)-5-chloroindolin-2-one (50 mg, 0.155 mmol) in dioxane/water (5% water) was added Cs2CO3 (152 mg, 0.466 mmol) and 4-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine (62 mg, 0.186 mmol). The mixture was degassed with nitrogen for 5 minutes then heated in microwave for 20 minutes at 120° C. The solution was diluted with water and the solid formed was isolated by filtration. The solid was purified by HPLC to yield 5-chloro-3-((5-(3-(2-morpholinoethoxy)phenyl)furan-2-yl)methylene)indolin-2-one. LCMS (M+1=451). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate In 1,4-dioxane-d8; water at 90℃; for 16h; Inert atmosphere; | 143 Example 143 tert-butyl lH-indazol-5-yl(2-(3-(2-morpholinoethoxy)phenyl)pyrimidin-4-yl)carbamate A mixture of compound 4-(2-(3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2- yl)phenoxy)ethyl)morpholine (1 g, 3.2 mmol), compound tert-butyl 5-((tert- butoxycarbonyl)(2-chloropyrimidin-4-yl)amino)-lH-indazole-l-carboxylate (670 mg, 1.5 mmol), K2CC"3 (414 mg, 3 mmol) and Pd(dppf)2Cl2 (109 mg, 0.15 mmol) in dioxane (20 mL) and H20 (5 mL) was heated at 90 °C for 16 hrs under N2 atmosphere. Then it was concentrated and the residue was purified by chromatography on silica gel column (eluted with DCM: MeOH = 100: 1 to 20: 1) to give the tile compound (380 mg, yield 50%) as a light red oil. |
50% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate In 1,4-dioxane; water at 90℃; for 16h; Inert atmosphere; | 143 Example 143 tert-butyl lH-indazol-5-yl(2-(3-(2-morpholinoethoxy)phenyl)pyrimidin-4-yl)carbamate Example 143 tert-butyl lH-indazol-5-yl(2-(3-(2-morpholinoethoxy)phenyl)pyrimidin-4-yl)carbamate A mixture of compound 4-(2-(3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2- yl)phenoxy)ethyl)morpholine (1 g, 3.2 mmol), compound tert-butyl 5-((tert-butoxycarbonyl)(2- chloropyrimidin-4-yl)amino)-lH-indazole-l-carboxylate (670 mg, 1.5 mmol), K2C03 (414 mg, 3 mmol) and Pd(dppf)2Cl2 (109 mg, 0.15 mmol) in dioxane (20 mL) and H20 (5 mL) was heated at 90 °C for 16 hrs under N2 atmosphere. Then it was concentrated and the residue was purified by chromatography on silica gel column (eluted with DCM: MeOH = 100: 1 to 20: 1) to give the tile compound (380 mg, yield 50%>) as a light red oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 90℃; for 16h; Inert atmosphere; | 142 Example 142 4-(2-(3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine A mixture of compound 4-(2-(3-bromophenoxy)ethyl)morpholine (1.1 g, 3.8 mmol), BIPN (1.47 mg, 5.8 mmol), KOAc (0.83 mg, 8.5 mmol) and Pd(dppf)2Cl2 (0.28 mg, 0.38 mmol) in dioxane (15 mL) was heated at 90 °C for 16 hrs under N2 atmosphere. Then it was concentrated and the residue was purified by chromatography on silica gel column (eluted with DCM : MeOH = 100 : 1 to 20 : 1) to give compound the title compound ( 1 g, yield 78%) as a light red oil. |
78% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 90℃; for 16h; Inert atmosphere; | 142 Example 142 4-(2-(3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine Example 142 4-(2-(3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine ] A mixture of compound 4-(2-(3-bromophenoxy)ethyl)morpholine (1.1 g, 3.8 mmol), BIPN (1.47 mg, 5.8 mmol), KOAc (0.83 mg, 8.5 mmol) and Pd(dppf)2Cl2 (0.28 mg, 0.38 mmol) in dioxane (15 mL) was heated at 90 °C for 16 hrs under N2 atmosphere. Then it was concentrated and the residue was purified by chromatography on silica gel column (eluted with DCM : MeOH = 100 : 1 to 20 : 1) to give compound the title compound ( 1 g, yield 78%) as a light red oil. |
With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In 1,4-dioxane at 90℃; for 12h; Inert atmosphere; | 5.2 Step 2: Synthesis of4-[2-[3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2- yl jphenoxy] ethyl ] morpholine 4-[2-(3-bromophenoxy)ethyl]morpholine (1 g, 3.49 mmol, 1.0 eq), PimEL (1.1 g, 4.33 mmol, 1.2 eq), Pd(dppf)Cl2-DCM (300 mg, 0.37 mmol, 0.1 eq) and KOAc (700 mg, 7.13 mmol, 2.0 eq) in dioxane (15.0 mL) was de-gassed and then heated to 90°C for 12 hours under N2. The reaction mixture was filtered and concentrated under reduced pressure to give 4-[2-[3- (4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2-yl)phenoxy]ethyl]morpholine (2.3 g, 84.9% yield, 43% purity) as a brown oil. LCMS [M+H]+ m/z :calcd 334.2, found 334.0. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium iodide; potassium carbonate / N,N-dimethyl-formamide / 16 h / 20 °C 2: (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate / 1,4-dioxane / 16 h / 90 °C / Inert atmosphere | ||
Multi-step reaction with 2 steps 1: potassium iodide; potassium carbonate / N,N-dimethyl-formamide / 16 h / 20 °C 2: potassium acetate; (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride / 1,4-dioxane / 16 h / 90 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate / water; 1,4-dioxane-d8 / 16 h / 90 °C / Inert atmosphere 2: trifluoroacetic acid / dichloromethane / 3 h / 20 °C | ||
Multi-step reaction with 2 steps 1: (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate / 1,4-dioxane; water / 16 h / 90 °C / Inert atmosphere 2: trifluoroacetic acid / dichloromethane / 3 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium iodide; potassium carbonate / N,N-dimethyl-formamide / 16 h / 20 °C 2: (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate / 1,4-dioxane / 16 h / 90 °C / Inert atmosphere | ||
Multi-step reaction with 2 steps 1: potassium iodide; potassium carbonate / N,N-dimethyl-formamide / 16 h / 20 °C 2: potassium acetate; (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride / 1,4-dioxane / 16 h / 90 °C / Inert atmosphere | ||
Multi-step reaction with 2 steps 1: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 12 h / 0 - 20 °C / Inert atmosphere 2: dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate / 1,4-dioxane / 12 h / 90 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 4-(2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-ethyl)morpholine; 4-bromo-N-alpha-[(trans-4-[(tert-butoxycarbonyl)amino]methyl}cyclohexyl)carbonyl]-N-[4-(2H-tetrazol-5-yl)phenyl]-L-phenylalaninamide With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In 1,2-dimethoxyethane; ethanol; water at 100℃; for 3h; Stage #2: trifluoroacetic acid In water; acetonitrile | 36.A tert-Butyl [(trans-4-[(2S)-3-{3-'-[2-(morpholin-4-yl)ethoxy]biphenyl-4-yl}-1-oxo-1-[4-(2H-tetrazol-5-yl)phenyl]amino}propan-2-yl]carbamoyl}cyclohexyl)methyl]carbamate trifluoroacetate Example 36A tert-Butyl [(trans-4-[(2S)-3-{3-'-[2-(morpholin-4-yl)ethoxy]biphenyl-4-yl}-1-oxo-1-[4-(2H-tetrazol-5-yl)phenyl]amino}propan-2-yl]carbamoyl}cyclohexyl)methyl]carbamate trifluoroacetate 18.4 mg (0.016 mmol) of tetrakis(triphenylphosphine)palladium(0) and 1.2 ml of 2M sodium carbonate solution in water were added to a solution of 100 mg (0.16 mmol) of 4-bromo-N-alpha-[(trans-4-[(tert-butoxycarbonyl)amino]methyl}cyclohexyl) carbonyl]-N-[4-(2H-tetrazol-5-yl)phenyl]-L-phenylalaninamide and 133.0 mg (0.4 mmol) of 4-{2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl}morpholine in 1.5 ml of 1,2-dimethoxyethane and 0.5 ml of ethanol. The mixture was stirred at 100° C. for 3 h. The mixture was filtered through kieselguhr and the filtrate was separated by preparative HPLC (mobile phase: gradient of acetonitrile/water with 0.1% trifluoroacetic acid). The product-containing fractions were combined and dried under high vacuum. 112 mg (63% of theory, 77% purity) of the title compound were obtained. LC-MS (Method 1): Rt=0.84 min; MS (ESIpos): m/z=753 [M+H-TFA]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / water; 1,2-dimethoxyethane; ethanol / 3 h / 100 °C 2: hydrogenchloride / water; 1,4-dioxane / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: N-ethyl-N,N-diisopropylamine / tetrahydrofuran / 0 - 20 °C 2: potassium carbonate / N,N-dimethyl-formamide / 8 h / 70 °C | ||
Multi-step reaction with 2 steps 1: triphenylphosphine; di-isopropyl azodicarboxylate / tetrahydrofuran / 12 h / 0 - 20 °C / Inert atmosphere 2: dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate / 1,4-dioxane / 12 h / 90 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 12 h / 90 °C / Inert atmosphere 2: hydrogen; palladium 10% on activated carbon / methanol / 4 h / 20 °C 3: triethylamine / dichloromethane / 1 h / -10 - 20 °C 4: triethylamine / dichloromethane / 16 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 12 h / 90 °C / Inert atmosphere 2: hydrogen; palladium 10% on activated carbon / methanol / 4 h / 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: potassium carbonate; tetrakis(triphenylphosphine) palladium(0) / 1,4-dioxane; water / 12 h / 90 °C / Inert atmosphere 2: hydrogen; palladium 10% on activated carbon / methanol / 4 h / 20 °C 3: triethylamine / dichloromethane / 1 h / -10 - 20 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In 1,4-dioxane; water at 90℃; for 12h; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39.3 mg | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; sodium carbonate In 1,2-dimethoxyethane; water at 130℃; for 0.5h; Microwave irradiation; | 8 (Example 8) 1-{4-methyl-5-[(2-{3-[2-(morpholine-4-yl)ethoxy]phenyl}pyridin-4-yl)oxy]-2,3-dihydro-1H-indole-1-yl}-2-[4-(methylsulfonyl)phenyl]ethanone The compound obtained in Example 3b (40.0 mg), 4-{2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl}morpholine (39.9 mg) and a [1 and 1' -bis (diphenylphospino) ferrocene] dichloropalladium (II) dichloromethane complex (6.51) The aqueous solution (0.5 mL) of sodium carbonate (25.4 mg) was added to the 1,2-dimethoxyethane (1.5 mL) solution of mg), and it was made to react to it for 30 minutes at 130 degrees C with a microwave reaction apparatus. Water was poured out after cooling reaction mixture to a room temperature, and ethyl acetate extracted 3 times. The mark compound (39.3 mg) was obtained as a colorless solid by refining the residue obtained by distilling off the bottom solvent of decompression after drying with anhydrous sodium sulfate in the doubled organic layer with silica gel column chromatography (ethyl acetate/hexane -> ethyl acetate/dichloromethane). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
41.5 mg | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; sodium carbonate In 1,2-dimethoxyethane; water at 130℃; for 0.5h; Microwave irradiation; | 14 (Example 14) 1-{4-methyl-5-[(2-{3-[2-(morpholine-4-yl)ethoxy]phenyl}pyrimidine-4-yl)oxy]-2,3-dihydro-1H-indole-1-yl}-2-[4-(methylsulfonyl)phenyl]ethanone The compound obtained in Example 11b (35.0 mg), 4-{2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl}morpholine (38.2 mg) and a [1 and 1' -bis (diphenylphospino) ferrocene] dichloropalladium (II) dichloromethane complex (6.24) The aqueous solution (0.5 mL) of sodium carbonate (24.3 mg) was added to the 1,2-dimethoxyethane (1.5 mL) solution of mg), and it was made to react to it for 30 minutes at 130 degrees C with a microwave reaction apparatus. Water was poured out after cooling reaction mixture to a room temperature, and ethyl acetate extracted 3 times. The mark compound (41.5 mg) was obtained as a colorless solid by refining the residue obtained by distilling off the bottom solvent of decompression after drying with anhydrous sodium sulfate in the doubled organic layer with amino silica gel column chromatography (ethyl acetate/hexane -> ethyl acetate/dichloromethane). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium carbonate; (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride / water; 1,4-dioxane / 3 h / 80 °C / Inert atmosphere 2: tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; caesium carbonate / 1,4-dioxane / 2 h / 130 °C / Microwave irradiation; Sealed tube; Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: potassium carbonate; (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride / water; 1,4-dioxane / 3 h / 80 °C / Inert atmosphere 2: tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; caesium carbonate / 1,4-dioxane / 2 h / 130 °C / Microwave irradiation; Sealed tube; Inert atmosphere 3: tetrabutyl ammonium fluoride / tetrahydrofuran / 1 h / 70 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: potassium carbonate; (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride / water; 1,4-dioxane / 3 h / 80 °C / Inert atmosphere 2: tris-(dibenzylideneacetone)dipalladium(0); 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; caesium carbonate / 1,4-dioxane / 2 h / 130 °C / Microwave irradiation; Sealed tube; Inert atmosphere 3: tetrabutyl ammonium fluoride / tetrahydrofuran / 1 h / 70 °C 4: cyanomethylenetributyl-phosphorane / toluene / 12 h / 130 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate In 1,4-dioxane; water at 80℃; for 3h; Inert atmosphere; | 5.3 Step 3: Synthesis oftert-butyl-[(3S)-3-[6-chloro-3-[3-(2-morpholinoethoxy)phenyl]pyrazolo[4,3- c ]pyridin-l -yl Jbutoxy] -dimethyl-silane [(3S)-3-(3-bromo-6-chloro-pyrazolo[4,3-c]pyridin-l-yl)butoxy]-tert-butyl- dimethyl-silane (700 mg, 1.67 mmol, 1.0 eq), 4-[2-[3-(4,4,5,5-tetramethyl-l,3,2-dioxaborolan-2- yl)phenoxy] ethyl] morpholine (2.3 g, 2.97 mmol, 43% purity, 1.8 eq), Pd(dppf)Cl2 (130 mg, 0.18 mmol, 0.1 eq) and K2CO3 (600 mg, 4.34 mmol, 2.6 eq) in dioxane (20.0 mL) and H2O (4.0 mL) was de-gassed and then heated to 80°C for 3 hours under N2. The resulting mixture was filtered and washed with EtOAc (20 mL * 3). The combined filtrate diluted with saturated Na2CC>3 aqueous solution (30 mL) and water (30 mL), and then extracted with EtOAc (60 mL). The combined organic layers were washed with brine (60 mL * 2), dried over Na2S04, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (ISCO; 40 g SepaLlash Silica Llash Column, petroleum ether/EtOAc with EtOAc from 0-100%, 100 mL/min, 254 nm) to afford tert-butyl-[(3S)-3-[6-chloro-3-[3-(2- morpholinoethoxy)phenyl]pyrazolo[4,3-c]pyridin-l-yl]butoxy]-dimethyl-silane (1.1 g, 91.8% yield, 76% purity) as a yellow oil. LCMS [M+H]+ m/z: calcd 545.3, found 545.1. NMR (400MHz, chloroform -r/) d ppm 9.07 (s, 1H), 7.56 - 7.50 (m, 2H), 7.45 (br d, J = 8.1 Hz, 1H), 7.42 (s, 1H), 7.01 (br d, J = 5.8 Hz, 1H), 4.91 (br t, J = 10.4 Hz, 1H), 4.22 (t, J = 5.7 Hz, 2H), 3.77 - 3.74 (m, 4H), 3.64 - 3.55 (m, 1H), 3.16 (dt, J = 3.3, 10.1 Hz, 1H), 2.87 (t, J = 5.6 Hz, 2H), 2.61 (br d, J = 4.6 Hz, 4H), 2.33 - 2.20 (m, 1H), 2.11 - 2.02 (m, 1H), 1.65 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), -0.04 (d, J = 15.3 Hz, 6H). |
[ 690636-28-3 ]
4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
Similarity: 0.99
[ 1704065-77-9 ]
4-(3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.96
[ 925940-40-5 ]
N,N-Dimethyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanamine
Similarity: 0.96
[ 925940-40-5 ]
N,N-Dimethyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanamine
Similarity: 0.96
[ 910462-33-8 ]
4-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.94
[ 690636-28-3 ]
4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
Similarity: 0.99
[ 1704065-77-9 ]
4-(3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.96
[ 925940-40-5 ]
N,N-Dimethyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanamine
Similarity: 0.96
[ 910462-33-8 ]
4-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.94
[ 690636-28-3 ]
4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
Similarity: 0.99
[ 1704065-77-9 ]
4-(3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.96
[ 925940-40-5 ]
N,N-Dimethyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanamine
Similarity: 0.96
[ 910462-33-8 ]
4-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.94
[ 690636-28-3 ]
4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
Similarity: 0.99
[ 1704065-77-9 ]
4-(3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.96
[ 925940-40-5 ]
N,N-Dimethyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethanamine
Similarity: 0.96
[ 1196396-94-7 ]
Diethyl({2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl})amine
Similarity: 0.96
[ 690636-28-3 ]
4-(2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine
Similarity: 0.99
[ 1704065-77-9 ]
4-(3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.96
[ 910462-33-8 ]
4-(3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propyl)morpholine
Similarity: 0.94